From [HERE] and [HERE] Dr Albert Bourla used an interview with the BBC last December to claim that “there is no doubt in my mind that the benefits, completely, are in favour of” vaccinating youngsters aged five to 11 against Covid-19. 

He argued that “Covid in schools is thriving” adding: “This is disturbing, significantly, the educational system, and there are kids that will have severe symptoms.”

The interview was published on Dec 2 - before the vaccine had been approved by Britain’s medical regulator for this age group. 

Shortly after the article’s publication, a complaint was submitted to the pharmaceutical watchdog - the Prescription Medicines Code of Practice Authority (PMCPA) - by UsForThem, a parent campaign group which was set up to promote the plight of children during the pandemic. 

‘Extremely promotional in nature’

The complaint alleged that Dr Bourla’s remarks about the children’s vaccine were “disgracefully misleading” and “extremely promotional in nature”, arguing that it breached several clauses of the Association of the British Pharmaceutical Industry’s (ABPI) code of practice. 

“There is simply no evidence that healthy schoolchildren in the UK are at significant risk from the SARS COV-2 virus and to imply that they are is disgracefully misleading,” they said. [MORE]